Search results for "Effects"

showing 10 items of 2634 documents

Association between night-time extubation and clinical outcomes in adult patients

2021

Background: Whether night-time extubation is associated with clinical outcomes is unclear. Objective: The aim of this systematic review and meta-analysis was to evaluate the association between night-time extubation and the reintubation rate, mortality, ICU and in-hospital LOS in adult patients, compared with daytime extubation. Design: A systematic review and meta-analysis. Data sources: PubMed, EMBASE, CINAHL and Web of Science from inception to 2 January 2021 (PROSPERO registration - CRD42020222812). Eligibility criteria: Randomised, quasi and cluster randomised, and nonrandomised studies describing associations between adult patients' outcomes and time of extubation (daytime/night-time)…

AdultMechanical ventilationmedicine.medical_specialtyextubationCritical CareAdult patientsbusiness.industrymedicine.medical_treatmentRetrospective cohort studyCINAHLLength of StayDisease clusterRandom effects modelRespiration ArtificialIntensive Care UnitsAnesthesiology and Pain MedicineMeta-analysisIntensive careEmergency medicineAirway ExtubationmedicineHumansbusinessRetrospective StudiesEuropean Journal of Anaesthesiology
researchProduct

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid…

2008

Abstract Imatinib mesylate, a targeted inhibitor of BCR-ABL tyrosine kinase, is the standard of care for chronic myeloid leukemia (CML). A phase 2 trial of imatinib in late chronic-phase (CP) CML after interferon-α (IFNα) failure enrolled 532 patients, 454 with a confirmed diagnosis of CP CML. Median time from diagnosis was 34 months; median duration of imatinib treatment was 65 months. Cumulative best rates of major cytogenetic response (MCyR) and complete cytogenetic response (CCyR) were 67% and 57%, respectively. At the 5-year landmark, 184 (41%) of the 454 patients are in CCyR. At more than 6 years, 199 (44%) of the 454 patients remain on imatinib. Most responses occurred within 12 mont…

AdultOncologymedicine.medical_specialtyTime FactorsAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.drug_classImmunologyimatinib CML interferon-alphaSalvage therapyBlastic PhaseBiochemistryPiperazinesTyrosine-kinase inhibitorhemic and lymphatic diseasesInternal medicinemedicineHumansneoplasmsSurvival rateAgedAged 80 and overSalvage Therapybusiness.industryInterferon-alphaMyeloid leukemiaImatinibCell BiologyHematologyMiddle Agedmedicine.diseaseSurgerySurvival RatePyrimidinesTreatment OutcomeImatinib mesylateBenzamidesLeukemia Myeloid Chronic-PhaseDisease ProgressionImatinib MesylatebusinessFollow-Up StudiesChronic myelogenous leukemiamedicine.drug
researchProduct

Network intervention analysis to assess the trajectory of change and treatment effects associated with the use of online guided self-help for anorexi…

2020

Aim The aim of this study was to use the innovative technique of Network Intervention Analysis (NIA) to examine the trajectory of symptom change associated with the use of a digital guided self-help intervention (RecoveryMANTRA) to augment treatment as usual in adult anorexia nervosa. Methods Self-reported eating disorder symptoms and mood (stress, anxiety and depression), work and social adjustment, motivation and treatment (Treatment as usual + RecoveryMANTRAand Treatment as usual) were included as nodes in the network and examined using NIA. Networks were computed at baseline (n = 88, 99), at end of treatment (6 weeks, n = 71, 75) and at 6- (n = 58, 63) and 12-month (n = 52, 63) follow-u…

Adultanorexia nervosa network intervention analysis outcome random ized clinical trial treatment effectsAnorexia Nervosaanorexia nervosa; network intervention analysis; outcome; randomized clinical trial; treatment effectsAnxietylaw.inventionSelf-helpRandomized controlled triallawIntervention (counseling)Settore M-PSI/08 - Psicologia ClinicaMedicineHumansBiological PsychiatryDepression (differential diagnoses)network intervention analysiMotivationbusiness.industrynetwork intervention analysistreatment effectsrandomized clinical trialAnxiety DisordersPsychiatry and Mental healthMoodAnorexia nervosa (differential diagnoses)outcomeAnxietyPshychiatric Mental Healthmedicine.symptomAugmentbusinessSocial AdjustmentClinical psychology
researchProduct

The number of anti-seizure medications mediates the relationship between cognitive performance and quality of life in temporal lobe epilepsy

2021

Abstract Objectives To assess whether cognitive performance predicts quality of life (QOL) in patients with drug-resistant temporal lobe epilepsy (TLE), using the Epitrack cognitive screening tool, while considering the mediating role of the number of anti-seizure medications (ASMs) and controlling for seizure-related, social, and emotional factors. Methods Seventy-five adult patients with drug-resistant TLE (mean age = 39.76 years, SD = 11.66) underwent a presurgical neuropsychological assessment. Main Outcome Measures: Cognitive performance (Epitrack), depression (BDI-II), trait anxiety (STAI); and QOL (QOLIE-31) were assessed. Results Adjusting for seizure-related, social, and emotional …

Adultmedia_common.quotation_subjectPopulationAnxietyNeuropsychological Tests03 medical and health sciencesBehavioral NeuroscienceEpilepsyCognition0302 clinical medicineQuality of lifemedicineHumans030212 general & internal medicineEffects of sleep deprivation on cognitive performanceNeuropsychological assessmentCognitive skilleducationmedia_commoneducation.field_of_studymedicine.diagnostic_testbusiness.industryCognitionmedicine.diseasehumanitiesEpilepsy Temporal LobeNeurologyQuality of LifeNeurology (clinical)Worrybusiness030217 neurology & neurosurgeryClinical psychologyEpilepsy & Behavior
researchProduct

Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

2001

The prevalence and pattern of cognitive impairment in systemic lupus erythematosus (SLE) patients with (NPSLE) and without (nSLE) overt neuropsychiatric manifestations were investigated. Fifty-two nSLE patients, 23 NPSLE patients and 27 healthy controls were evaluated with a battery of standardized neuropsychological and psychological tests. Disease duration, disease activity index, and current corticosteroid therapy were collected. Cognitive impairment was identified in 14 (26.9%) and in 12 (52.2%) of subjects with nSLE and NPSLE, respectively. Both SLE groups showed a significant impairment compared with controls on tasks assessing verbal and non-verbal long-term memory, and visuoconstruc…

Adultmedicine.medical_specialtyAnxietyNeuropsychological TestsMental ProcessesAdrenal Cortex HormonesMemoryInternal medicinemedicineHumansLupus Erythematosus SystemicSpeechSystemic lupus erythematosus Neuropsychiatric SLE Cognitive impairment Neuropsychology DepressionAttentionPsychological testingEffects of sleep deprivation on cognitive performanceDepression (differential diagnoses)Psychiatric Status Rating ScalesLupus erythematosusDepressionCognitive disorderNeuropsychologymedicine.diseaseConnective tissue diseaseMemory Short-TermNeurologyMental RecallPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)Cognition DisordersPsychologyPsychomotor PerformancePsychopathologyJournal of the Neurological Sciences
researchProduct

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovaria…

2013

Summary Background In the Gynecologic Cancer Intergroup International Collaboration on Ovarian Neoplasms 7 (ICON7) trial, bevacizumab improved progression-free survival in patients with ovarian cancer when used in combination with first-line chemotherapy and as a single-drug continuation treatment for 18 cycles. In a preliminary analysis of a high-risk subset of patients, there was also an improvement in overall survival. This study aims to describe the health-related quality-of-life (QoL) outcomes from ICON7. Methods ICON7 is a randomised, multicentre, open-label phase 3 trial. Between Dec 18, 2006, and Feb 16, 2009, after a surgical procedure aiming to debulk the disease, women with Inter…

Adultmedicine.medical_specialtyBevacizumabDrug-Related Side Effects and Adverse ReactionsAntibodies Monoclonal HumanizedDisease-Free Survivallaw.inventionchemistry.chemical_compoundRandomized controlled trialQuality of lifelawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAgedNeoplasm StagingOvarian NeoplasmsIntention-to-treat analysisbusiness.industryStandard treatmentArticlesMiddle Agedmedicine.diseaseCarboplatinSurgeryBevacizumabClinical trialTreatment OutcomeOncologychemistryQuality of LifeFemaleOvarian cancerbusinessmedicine.drugThe Lancet Oncology
researchProduct

Direct and Indirect Effects of Function in Associated Variables Such as Depression and Severity on Pain Intensity in Women with Carpal Tunnel Syndrome

2015

Objective To determine the direct and indirect effects of function on clinical variables such as age, pain intensity, years of the disease, severity of symptoms, and depression in women with electrodiagnostic and clinical diagnosis of carpal tunnel syndrome (CTS). Design A cross-sectional study. Setting Patients from an urban hospital referred to a university clinic. Methods Two hundred and forty-four (n = 224) women with CTS were included. Demographic and clinical data, duration of symptoms, function, symptom's severity of the symptoms, pain intensity, and depression were self-reported collected. Correlation and path analysis with maximum likelihood estimation were conducted to assess the …

Adultmedicine.medical_specialtyClinical variablesMaximum likelihoodPainDiseaseComorbiditySensitivity and SpecificitySeverity of Illness IndexRisk FactorsPrevalenceMedicineHumansCarpal tunnel syndromeAgedPain MeasurementHand functionbusiness.industryDepressionDirect effectsReproducibility of ResultsGeneral MedicineRecovery of FunctionMiddle Agedmedicine.diseaseCarpal Tunnel SyndromeCausalityAnesthesiology and Pain MedicineCross-Sectional StudiesPsicobiologiaSpainClinical diagnosisPhysical therapyNeuralgiaWomen's HealthFemaleNeurology (clinical)Self ReportSymptom AssessmentbusinessUrban hospital
researchProduct

Prenatal Exposure to Polybrominated Flame Retardants and Fetal Growth in the INMA Cohort (Spain)

2015

Our aim was to investigate the relation between PBDEs and fetal growth or newborn anthropometry in a Spanish cohort (2003-2008). PBDE congeners (BDE-47, -99, -153, -154, and -209) were determined in serum of 670 mothers at gestational week 12 and in 534 umbilical cord samples. Abdominal circumference (AC), estimated fetal weight (EFW), femur length (FL), and biparietal diameter (BPD) during gestation were measured by ultrasounds. At birth, weight (BW), head circumference (HC), and length (BL) were also measured. We assessed growth in the intervals between 12-20 and 20-34 weeks of gestation and size at birth by standard deviation (SD)-scores adjusted for constitutional characteristics. We co…

Adultmedicine.medical_specialtyFetal monitoring010501 environmental sciences01 natural sciencesUmbilical cordFlame retardantsArticleUltrasonography PrenatalCohort StudiesFetal Development03 medical and health sciences0302 clinical medicinePregnancyBayesian multivariate linear regressionInternal medicinePrenatal exposureHalogenated Diphenyl EthersmedicineFetal growthBody SizeHumansEnvironmental ChemistryPregnancy exposome030212 general & internal medicine0105 earth and related environmental sciencesPregnancyObstetricsbusiness.industryBody WeightInfant NewbornGeneral ChemistryAnthropometrymedicine.disease3. Good healthEndocrinologymedicine.anatomical_structureSpainPrenatal Exposure Delayed EffectsCohortGestationFemalebusinessCohort study
researchProduct

Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI

2014

none 10 no The dramatic demographic changes that are occurring in the third millennium are modifying the mission of generalist professionals such as primary care physicians and internists. Multiple chronic diseases and the related prescription of multiple medications are becoming typical problems and present many challenges. Unfortunately, the available evidence regarding the efficacy of medications has been generated by clinical trials involving patients completely different from those currently admitted to internal medicine: much younger, affected by a single disease and managed in a highly controlled research environment. Because only registries can provide information on drug effectiven…

Adverse drug effects; Aging; Drug prescription; Multidimensional evaluation; Multimorbidity; Polypharmacy; Aged; Aged; 80 and over; Female; Humans; Internal Medicine; Italy; Male; Registries; Societies; Medical; Comorbidity; Geriatrics; Polypharmacy; Internal Medicine; Emergency MedicineMalemedicine.medical_specialtyAgingmedia_common.quotation_subjectDrug prescriptionMEDLINEAdverse drug effects; Aging; Drug prescription; Multidimensional evaluation; Multimorbidity; Polypharmacy; Aged; Aged 80 and over; Female; Humans; Internal Medicine; Italy; Male; Registries; Societies Medical; Comorbidity; Geriatrics; Polypharmacy; Internal Medicine; Emergency MedicineDiseaseComorbidityAdverse drug effects; Aging; Drug prescription; Multidimensional evaluation; Multimorbidity; PolypharmacyelderlyAdverse drug effectsPromotion (rank)MedicalmedicineAdverse drug effect80 and overInternal MedicineHumansRegistriesMedical prescriptionmedia_commonAgedGeriatricsPolypharmacyAdverse drug effects; Aging; Drug prescription; Multidimensional evaluation; Multimorbidity; Polypharmacy; Emergency Medicine; Internal MedicineMultimorbidity Polypharmacy Aging Drug prescription Multidimensional evaluation Adverse drug effectsMultidimensional evaluationbusiness.industrySettore MED/09 - MEDICINA INTERNAMultimorbiditymedicine.diseaseComorbidityelderly multimorbidity polypharmacyClinical trialItalyGeriatricsFamily medicinePolypharmacyEmergency MedicineFemaleMedical emergencyAdverse drug effects; Aging; Drug prescription; Multidimensional evaluation; Multimorbidity; Polypharmacy; Internal Medicine; Emergency MedicinebusinessSocietiesmultimorbidity; polypharmacy; aging; drug prescription; multidimensional evaluation; adverse drug effectsMultimorbidity; Polypharmacy; Aging; Drug prescription; Multidimensional evaluation
researchProduct

When Affective (But Not Cognitive) Ambivalence Predicts Discrimination Toward a Minority Group

2013

Individuals often hold ambivalent attitudes (i.e., positive and negative attitudes at the same time) toward groups and social categories. The aim of the present research was to examine the differential effects of affective and cognitive dimensions of ambivalence on the (amplification of) responses towards a minority group. We asked 188 students from the University of Perugia to read a short description of a fictitious group of immigrants. After expressing their affective and cognitive attitudes toward the target group, participants received positive, negative, or no supplementary information about this group. Discrimination was assessed by asking participants to allocate to the target group…

Affective ambivalenceAdultMaleMinority groupSocial Psychologymedia_common.quotation_subjectImmigrationEmigrants and ImmigrantsAffect (psychology)AmbivalenceYoung AdultCognitive dimensions of notationsCognitionDiscriminationHumansYoung adultMinority GroupStudentsMinority Groupsmedia_commonStereotypingEmigrants and ImmigrantCognitionDifferential effectsAffectAttitudeItalyCognitive ambivalenceFemaleStudentPsychologySettore M-PSI/05 - Psicologia SocialeSocial psychologyPrejudiceHumanThe Journal of Social Psychology
researchProduct